Related Experiment Video
Updated: Aug 8, 2026
07:25
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
Cancer and male sexual dysfunction
1Uniformed Services University, Fort Lewis, Washington, USA.
Oncology (Williston Park, N.Y.)
|March 29, 2000
Summary
Cancer treatments can cause erectile dysfunction (ED) in men, stemming from physical and psychological factors. Effective management requires understanding erection mechanisms and available therapies for improved patient outcomes.
Area of Science:
- Oncology
- Urology
- Men's Health
Background:
- Cancer treatments frequently lead to erectile dysfunction (ED) in male patients.
- ED in this population is often multifactorial, involving both physiological and psychological causes.
- Understanding the pathophysiology of ED is crucial for effective management.
Purpose of the Study:
- To provide a comprehensive overview of erectile dysfunction in men undergoing cancer treatment.
- To discuss the pathophysiology, evaluation, and treatment options for ED in cancer patients.
- To highlight the importance of understanding erection mechanisms for successful therapeutic interventions.
Main Methods:
- Review of current literature on erectile dysfunction in cancer patients.
- Analysis of the physiological and psychological mechanisms underlying ED.
- Compilation of available treatment modalities, including mechanical, surgical, and pharmacologic options.
- Discussion of recent advancements in understanding erection at organ, cellular, and molecular levels.
Main Results:
- Erectile dysfunction is a common complication of cancer therapy with diverse etiologies.
- A range of treatment strategies, from mechanical aids to systemic drugs, are available.
- Advances in understanding erection physiology have enabled novel therapeutic approaches.
- Successful ED treatment hinges on provider expertise in erection mechanisms and therapies.
Conclusions:
- Effective management of erectile dysfunction in cancer patients requires a thorough understanding of its causes and available treatments.
- New insights into erection mechanisms have led to improved therapeutic options.
- This article serves as a guide to the pathophysiology, evaluation, and treatment of ED in this patient group.
Related Concept Videos
01:28Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
01:24Disorders of the Female Reproductive System
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
01:20Disorders of the Male Reproductive System
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
01:21Nursing Assessment of the Genitourinary System I: Health History
The genitourinary system is critical to maintaining fluid balance, waste elimination, and reproductive function. Nurses play a vital role in assessing this system, beginning with a thorough health history. This process involves gathering patient information, identifying risk factors, and recognizing symptoms of genitourinary disorders. Early detection is vital for timely interventions and management.1. Gathering Patient InformationA complete health history includes the patient’s personal,...
01:28Amebiasis
Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
01:23Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...